From January 1, 2024 to March 31, 2024, the company has repurchased 1,267,900 shares, representing 0.09% for CNY 34.98 million. With this, the company has completed the repurchase of 1,488,200 shares, representing 0.11% for CNY 39.23 million under the buyback announced on September 21, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
32.82 CNY | +0.12% | -6.58% | +7.55% |
22/04 | CSPC Innovation Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
19/04 | China's drugmakers can't sell mRNA shots but haven't quit yet | RE |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+7.55% | 638.54Cr | |
+17.39% | 847.6Cr | |
+6.26% | 759.52Cr | |
-7.57% | 370.82Cr | |
-5.30% | 374.96Cr | |
-1.78% | 135.51Cr | |
-27.39% | 110.76Cr | |
+18.29% | 102.38Cr | |
-9.48% | 92Cr | |
-18.72% | 78Cr |
- Stock Market
- Equities
- 300765 Stock
- News CSPC Innovation Pharmaceutical Co., Ltd.
- Tranche Update on CSPC Innovation Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on September 21, 2023.